| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
Address all correspondence and requests for reprints to: Per-Ola Carlsson, M.D., Department of Medical Cell Biology, Biomedical Center, P.O. Box 571, S-75123 Uppsala, Sweden.
The present study tested the hypothesis that changes in pancreatic islet blood flow correlate with the difference in diabetes incidence between male and female nonobese diabetic (NOD) mice. The blood flows were determined by a microsphere technique. In animals aged 10 and 14 weeks, the islet blood perfusion was 3-fold higher in female NOD mice compared with that in either age-matched male NOD mice or age- and sex-matched control ICR mice. At 5 weeks of age islet blood flow was similar in all groups. No differences between male and female NOD mice in whole pancreatic, duodenal, ileal, or colonic blood flows were observed at any time point. Administration of a bolus dose of aminoguanidine (a blocker of inducible nitric oxide synthase) to 10-week-old animals selectively and markedly decreased islet blood flow in female NOD mice, whereas islet blood flow in ICR mice and male NOD mice remained unaffected. Aminoguanidine did not affect mean arterial blood pressure or whole pancreatic blood flow in any of the groups. Injection of NG-methyl-L-arginine, an unspecific inhibitor of both constitutive and inducible nitric oxide synthase, markedly decreased whole pancreatic and islet blood flow to the same level in both male and female NOD mice. These combined findings suggest that diabetes-prone female NOD mice have an increased islet blood flow, which is mediated by an excessive production of nitric oxide formed by inducible nitric oxide synthase. The islet blood hyperperfusion may augment homing to the pancreatic islets of inflammatory cells and soluble factors involved in ß-cell destruction during the development of insulin-dependent diabetes mellitus in this animal model. The presently observed gender difference in the blood flow response could, therefore, at least partially explain why female NOD mice are more prone to develop hyperglycemia than the males.
This article has been cited by other articles:
 |
|
 |
|
  Z. Medarova, G. Castillo, G. Dai, E. Bolotin, A. Bogdanov, and A. Moore Noninvasive Magnetic Resonance Imaging of Microvascular Changes in Type 1 Diabetes Diabetes, November 1, 2007; 56(11): 2677 - 2682. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Reddy, Y. Hao, S.-H. Lee, S. R. Gangireddy, C. Owyang, and M. J. DiMagno Pioglitazone reverses insulin resistance and impaired CCK-stimulated pancreatic secretion in eNOS(-/-) mice: therapy for exocrine pancreatic disorders? Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G112 - G120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Denis, U. Mahmood, C. Benoist, D. Mathis, and R. Weissleder Imaging inflammation of the pancreatic islets in type 1 diabetes PNAS, August 24, 2004; 101(34): 12634 - 12639. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Iwase, Y. Uchizono, K. Tashiro, D. Goto, and M. Iida Islet Hyperperfusion During Prediabetic Phase in OLETF Rats, a Model of Type 2 Diabetes Diabetes, August 1, 2002; 51(8): 2530 - 2535. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.-O. Carlsson, M. Flodstrom, and S. Sandler Islet Blood Flow in Multiple Low Dose Streptozotocin-Treated Wild-Type and Inducible Nitric Oxide Synthase-Deficient Mice Endocrinology, August 1, 2000; 141(8): 2752 - 2757. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
